Skip to main content

Table 1 Anthropometric and clinical characteristics

From: Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type

  

(Range)

Race (MA/C/AA)

22/11/3

 

Age (y)

55 ± 2

(32–70)

Duration of Diabetes

6 ± 1

(1–16)

Diet/SU therapy

20/16

 

Body Weight (kg)

89 ± 3

(60–119)

Height (cm)

172 ± 1

(156–192)

Body Mass Index (kg/m2)

30 ± 1

(22.9–38.9)

Body Surface Area (m2)

2.05 ± 0.03

(1.61–2.52)

Fat Mass (kg)

31 ± 2

(13.6–51.5)

Fasting Plasma Glucose (mg/dl)

199 ± 7

(101–265)

Fasting Plasma Insulin (μU/ml)

15 ± 1

(5.5–39.1)

HbA1c (%)

9.0 ± 0.2

(6.8–11.9)

Fasting Free Fatty Acid (μEq/L)

589 ± 22

(320–921)

Basal EGP (mg/kg FFM·min)

3.0 ± 0.1

(1.74–4.64)

Clamp EGP (mg/kg FFM·min)

1.2 ± 0.1

(0.2–2.2)

TGD (mg/kg FFM·min)

3.5 ± 0.2

(1.6–7.7)

SSPI

67 ± 2

(44–84)

Clamp EGP × SSPI

76 ± 7

(10–156)

TGD/SSPI

0.05 ± 0.003

(0.02–0.10)

Clamp FFA (μEq/L)

230 ± 13

(118–389)

VF (cm2)

159 ± 9

(75–337)

SF (cm2)

303 ± 21

(108–651)

VF/SF Ratio

0.59 ± 0.04

(0.17–1.30)

Deep SF (cm2)

199 ± 14

(53–418)

Superficial SF (cm2)

104 ± 8

(44–232)

  1. MA = Mexican American; C = Caucasian; AA = African American
  2. FFM = fat free mass (kg)
  3. EGP = endogenous glucose production rate
  4. Clamp EGP = endogenous glucose production rate during insulin clamp
  5. SSPI = steady state plasma insulin concentration during insulin clamp
  6. Clamp FFA = plasma free fatty acid concentration during insulin clamp
  7. TGD = total glucose disposal rate during insulin clamp
  8. Clamp EGP × SSPI = product of the Clamp EGP and steady state plasma insulin concentration during insulin clamp (index of hepatic insulin resistance)
  9. TGD/SSPI = TGD divided by SSPI (index of peripheral [muscle] insulin sensitivity)
  10. VF = visceral fat area at L4–5
  11. SF = subcutaneous fat area at L4–5
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840